Template:Anticholinergic Toxicity Treatement: Difference between revisions

Line 1: Line 1:
==Treatment==
==Treatment==
*Consider GI decon with [[Activated Charcoal]]
*Consider GI decon with [[Activated Charcoal]] if patient presents <2 hours after ingestion and remains cooperative
*Sedation
*Sedation
**Decreases the risk of [[hyperthermia]], [[rhabdo]], traumatic injuries
**Decreases the risk of [[hyperthermia]], [[rhabdo]], traumatic injuries
**[[Benzos]] are agents of choice especially increase seizure threshold
**[[Benzos]] are agents of choice especially increase seizure threshold
**Repeat boluses every 5-15 minutes as needed to halt seizures and provide adequate sedation
*[[Sodium bicarbonate]] for conduction abnormalities (QRS prolongation)
*[[Sodium bicarbonate]] for conduction abnormalities (QRS prolongation)
**2 mEq/kg bolus (typically 2-3 amps of bicarb)
**2 mEq/kg bolus (typically 2-3 amps of bicarb)
**Begin continuous NaCO3 infusion at 250mL/hr if bolus effective   
**Begin continuous NaCO3 infusion at 250mL/hr if bolus effective   
**Solution preparation = 1L D5W mixed with 3 ampules NaHCO3
**Solution preparation = 1L D5W mixed with 3 ampules NaHCO3
**Goal: QRS duration < 110 msec
*Cholinesterase inhibition
*Cholinesterase inhibition
**Indicated for severe agitation or delirium (esp if unresponsive to [[benzos]])
**Indicated for severe agitation or delirium (esp if unresponsive to [[benzos]])
**Contraindicated in QRS>100 or Na blockade signs (R' in aVR)
**Contraindicated in QRS>100 or Na blockade signs (R' in aVR) and in narrow angle glaucoma
**Relatively contraindicated in asthma or ileus
**Relatively contraindicated in asthma or ileus
**[[Physostigmine]] - strongly consider poison control consult before giving
**[[Physostigmine]] - strongly consider poison control consult before giving
***Crosses blood brain barrier, can be used to help make dx
***Crosses blood brain barrier, can be used to help make dx
***Dosing: 0.5-2mg IV over 5min
***Dosing: 1-2mg IV over 5min
***Onset of action: 15-20min
***Onset of action: 5-10min
***If partial response, repeat x3
***If 3 or more administrations are needed over a 6-hour period, start IV infusion (bolus 1-2 mg followed by 1 mg/hour)
***Stop infusion every 12 hours to determine resolution of the toxidrome
***Side effects: bradycardia, dysrhythmias, cholinergic excess
***Side effects: bradycardia, dysrhythmias, cholinergic excess
***Always have [[atropine]] at the bedside for bradycardia or cholinergic excess
***Always have [[atropine]] at the bedside for bradycardia or cholinergic excess
***'''Contraindicated''' in [[TCA toxicity]] (associated with cardiac arrest) and in the presence of bradycardia or AV block
***'''Contraindicated''' in [[TCA toxicity]] (associated with cardiac arrest) and in the presence of bradycardia or AV block

Revision as of 12:32, 1 September 2019

Treatment

  • Consider GI decon with Activated Charcoal if patient presents <2 hours after ingestion and remains cooperative
  • Sedation
    • Decreases the risk of hyperthermia, rhabdo, traumatic injuries
    • Benzos are agents of choice especially increase seizure threshold
    • Repeat boluses every 5-15 minutes as needed to halt seizures and provide adequate sedation
  • Sodium bicarbonate for conduction abnormalities (QRS prolongation)
    • 2 mEq/kg bolus (typically 2-3 amps of bicarb)
    • Begin continuous NaCO3 infusion at 250mL/hr if bolus effective
    • Solution preparation = 1L D5W mixed with 3 ampules NaHCO3
    • Goal: QRS duration < 110 msec
  • Cholinesterase inhibition
    • Indicated for severe agitation or delirium (esp if unresponsive to benzos)
    • Contraindicated in QRS>100 or Na blockade signs (R' in aVR) and in narrow angle glaucoma
    • Relatively contraindicated in asthma or ileus
    • Physostigmine - strongly consider poison control consult before giving
      • Crosses blood brain barrier, can be used to help make dx
      • Dosing: 1-2mg IV over 5min
      • Onset of action: 5-10min
      • If partial response, repeat x3
      • If 3 or more administrations are needed over a 6-hour period, start IV infusion (bolus 1-2 mg followed by 1 mg/hour)
      • Stop infusion every 12 hours to determine resolution of the toxidrome
      • Side effects: bradycardia, dysrhythmias, cholinergic excess
      • Always have atropine at the bedside for bradycardia or cholinergic excess
      • Contraindicated in TCA toxicity (associated with cardiac arrest) and in the presence of bradycardia or AV block